Search research articles
Contact Us
Filters
Showing results (201-210 of 252) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Radiology
|
March 1, 1990
von Hippel-Lindau disease: radiologic screening for visceral manifestations
P L Choyke, M R Filling-Katz, T H Shawker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer
K S Bauer, W D Figg, J M Hamilton, et al.
The Journal of Urology
|
July 20, 1999
Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas
S E Strup, R O Pozzatti, C D Florence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1993
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI
S Maurea, A Cuocolo, J C Reynolds, et al.
Genomics
|
September 2, 1998
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer
K A Cole, R F Chuaqui, K Katz, et al.
Cancer Research
|
May 1, 1998
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene
L Schmidt, K Junker, G Weirich, et al.
Science (New York, N.Y.)
|
September 8, 1995
Inhibition of transcription elongation by the VHL tumor suppressor protein
D R Duan, A Pause, W H Burgess, et al.
Journal of the National Cancer Institute
|
April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Endocrinology
|
November 1, 1992
Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay
M M Walther, P J Kragel, E Trahan, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 252) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Radiology
|
March 1, 1990
von Hippel-Lindau disease: radiologic screening for visceral manifestations
P L Choyke, M R Filling-Katz, T H Shawker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer
K S Bauer, W D Figg, J M Hamilton, et al.
The Journal of Urology
|
July 20, 1999
Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas
S E Strup, R O Pozzatti, C D Florence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1993
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI
S Maurea, A Cuocolo, J C Reynolds, et al.
Genomics
|
September 2, 1998
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer
K A Cole, R F Chuaqui, K Katz, et al.
Cancer Research
|
May 1, 1998
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene
L Schmidt, K Junker, G Weirich, et al.
Science (New York, N.Y.)
|
September 8, 1995
Inhibition of transcription elongation by the VHL tumor suppressor protein
D R Duan, A Pause, W H Burgess, et al.
Journal of the National Cancer Institute
|
April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Endocrinology
|
November 1, 1992
Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay
M M Walther, P J Kragel, E Trahan, et al.
Page
of 26